Sartorius is an international partner to life sciences research and the biopharmaceutical industry, operating laboratory and bioprocess divisions with around 60 production and sales sites worldwide.
Oscar-Werner serves as chief technical officer at Sartorius and chairs the board at Deutsches Forschungszentrum für Künstliche Intelligenz. He also sits on the board of governors at the Technion, Israel Institute of Technology.
Sartorius took a minority shareholding in the London startup through its corporate venture unit to support product commercialisation.
"The SPARTA platform will help customers optimize the design of nanoparticles at an early stage, even before the drug candidates move on to the clinic. We have teamed up to bring additional product commercialization and application expertise to the table to facilitate a swift transitioning from prototype to launch,"
— Oscar-Werner Reif, Head of Corporate Research and CTO